Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Nimotuzumab”

149 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 149 results

Early research (Phase 1)Not Yet RecruitingNCT07053735
What this trial is testing

An Exploratory Clinical Study of Nimotuzumab in Bladder - Sparing Chemoradiotherapy for Muscle - Invasive Bladder Cancer

Who this might be right for
Bladder (Urothelial, Transitional Cell) Cancer
Peking University First Hospital 30
Not applicableNot Yet RecruitingNCT07388095
What this trial is testing

Adebrelimab Neoadjuvant Treatment for Resectable ESCC

Who this might be right for
ESCC
Tianjin Medical University Cancer Institute and Hospital 22
Large-scale testing (Phase 3)WithdrawnNCT01345084
What this trial is testing

Study Comparing Radiation Therapy and Chemotherapy With or Without Nimotuzumab

Who this might be right for
CarcinomaHead and Neck Cancer
Eurofarma Laboratorios S.A.
Testing effectiveness (Phase 2)UnknownNCT04136600
What this trial is testing

EGFR Monoclonal Antibody for Advanced Gastric Cancer

Who this might be right for
Gastric CancerCetuximabNimotuzumab
Shanghai Changzheng Hospital 100
Testing effectiveness (Phase 2)Enrolling By InvitationNCT07386704
What this trial is testing

Nimotuzumab Combined With Chemoradiotherapy in the Treatment of Unresectable Locally Advanced or Oligometastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer Non-resectable
Peking University First Hospital 30
Large-scale testing (Phase 3)Looking for participantsNCT07445048
What this trial is testing

Postoperative Radiotherapy Combined With Nimotuzumab Followed by Benmelstobart in High-Risk Patients With Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head & Neck Squamous Cell CarcinomaHead & Neck CancerPostoperative Adjuvant Treatment
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University 370
Not applicableStudy completedNCT00561873
What this trial is testing

Nimotuzumab in Children With HGG

Who this might be right for
High Grade Glioma
Oncoscience AG 45
Testing effectiveness (Phase 2)Ended earlyNCT00369447
What this trial is testing

Nimotuzumab in Combination With External Radiotherapy in Non-Small Cell Lung Cancer

Who this might be right for
Non-small-cell Lung Cancer
YM BioSciences 52
Testing effectiveness (Phase 2)UnknownNCT01336049
What this trial is testing

Nimotuzumab Plus Paclitaxel and Cisplatin as 1st Line Treatment for Esophageal Squamous Cell Cancer

Who this might be right for
Esophageal Squamous Cell Cancer
Peking University 70
Testing effectiveness (Phase 2)UnknownNCT02858206
What this trial is testing

Simultaneous Integrated Boost Radiotherapy and Concurrent Nimotuzumab or Chemotherapy for Esophageal Carcinoma

Who this might be right for
Esophageal Neoplasms
Chinese Academy of Medical Sciences 120
Testing effectiveness (Phase 2)Study completedNCT00702481
What this trial is testing

Study of Nimotuzumab and Cisplatin/Radiotherapy for Locally Advanced Head and Neck Squamous Cell Cancer

Who this might be right for
Head and Neck Cancer
National Cancer Centre, Singapore 32
Testing effectiveness (Phase 2)UnknownNCT00972465
What this trial is testing

Study of Nimotuzumab to Treat Colorectal Cancer

Who this might be right for
Advanced Colorectal Cancer
Peking University 48
Testing effectiveness (Phase 2)UnknownNCT03400592
What this trial is testing

Study of Nimotuzumab and Irinotecan as Second Line With Recurrent or Metastatic Gastric Adenocarcinoma

Who this might be right for
Stomach Neoplasms
Peking University 55
Testing effectiveness (Phase 2)UnknownNCT04833205
What this trial is testing

Clinical Efficacy and Safety of EGFR-TKI Combined With Nimotuzumab in the Treatment of Leptomeningeal Metastases From Lung Cancer

Who this might be right for
Leptomeningeal MetastasisLung Cancer
Hui Bu 30
Testing effectiveness (Phase 2)Study completedNCT06048913
What this trial is testing

Nimotuzumab Combined With Concurrent Chemoradiotherapy for Locally Advanced Treatment Esophageal Cancer in Old Age

Who this might be right for
Esophageal Carcinoma
The First Affiliated Hospital with Nanjing Medical University 56
Testing effectiveness (Phase 2)Active Not RecruitingNCT06429904
What this trial is testing

Nimotuzumab Plus NALIRIFOX in Locally Advanced Pancreatic Cancer

Who this might be right for
Locally Advanced Pancreatic Cancer
Peking Union Medical College Hospital 31
Testing effectiveness (Phase 2)Study completedNCT03025958
What this trial is testing

Radiation Plus Concurrent Nimotuzumab in Elderly Patients With Locoregionally Advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Zhejiang Cancer Hospital 30
Large-scale testing (Phase 3)Study completedNCT02012062
What this trial is testing

Concurrent Nimotuzumab Versus Cisplatin With Radiotherapy for Locoregionally Advanced NPC

Who this might be right for
Nasopharyngeal Carcinoma
Fudan University 160
Testing effectiveness (Phase 2)Study completedNCT04207918
What this trial is testing

A Phase II Study of Chemoradiotherapy With Nimotuzumab in Unresectable Esophageal Cancer

Who this might be right for
Esophageal CancerChemoradiotherapyNimotuzumab+1 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 55
Large-scale testing (Phase 3)Looking for participantsNCT05978050
What this trial is testing

Nimotuzumab Combined With Paclitaxel for Recurrent Metastatic Gastric or Esophagogastric Junction Adenocarcinoma

Who this might be right for
Gastric or Esophagogastric Junction Adenocarcinoma
Biotech Pharmaceutical Co., Ltd. 354
Load More Results